Month: January 2015

Mergers & Acquisitions

BGC Announces Contingent Increase of All-Cash Tender Offer To Acquire GFI Group to $5.85 Per Share and Immediate Non-Contingent Increase to $5.75 Per Share

January 15, 2015 0

BGC Announces Contingent Increase of All-Cash Tender Offer To Acquire GFI Group to $5.85 Per Share and Immediate Non-Contingent Increase to $5.75 Per Share Contingent Increase Depends Upon Determination of Superiority by GFI Special Committee and Board Urges GFI Shareholders to Vote AGAINST the Inferior CME/GFI Management Transaction and Tender Their Shares to BGC PR Newswire NEW YORK, Jan. 15, 2015 NEW YORK , Jan. 15, 2015 /PRNewswire/ — BGC Partners, Inc. […]

Stock Analysts

Will Infineon Gain from the International Rectifier Buyout?

January 15, 2015 0

Shares of German chipmaker Infineon Technologies AG ( IFNNY ) rose around 2% on Jan 14 during the trading session on the NYSE, following completion of the acquisition of International Rectifier Corp. The buyout of this El Segundo, CA-based company strengthens Infineon’s position in the power semiconductors industry. […]

Stock Analysts

Shell Shuts Al Karaana Project due to High Capital Costs

January 15, 2015 0

Integrated energy major Royal Dutch Shell plc ( RDS.A ) announced that it will not move ahead with the Al Karaana petrochemicals project and will suspend further works on it. The project, a joint venture of Shell and Qatar Petroleum, was started in Dec 2011 with the signing of a Heads of Agreement (“HOA”) between the two. The companies had contemplated the construction a new world-scale petrochemical facility in the Ras Laffan Industrial City, north of Qatar […]

Stock Analysts

Eni Expands Its Portfolio in Egypt with Two More Blocks

January 15, 2015 0

Italian explorer EniSpA ( E ) has further strengthened its Egyptian presence after signing new concession agreements permitting it to explore two more blocks namely the North Leil and Karawan in offshore Egypt. Eni, the operator, holds 100% interest in North Leil and 50% stake in Karawan. The remaining 50% of Karawan is held by BP plc ( BP ). […]

Stock Analysts

Agilent Arm/Cell Signaling Tie for Companion Diagnostics

January 15, 2015 0

In an effort to expand in the growing companion diagnostics market, Dako, an Agilent Technologies ( A ) subsidiary, recently entered into a strategic partnership with Cell Signaling Technology to develop antibodies in the field of companion diagnostics for cancer-fighting drugs. Financial terms of the deal have not been disclosed. Agilent acquired the Danish cancer diagnostics company, Dako, for $2.2 billion (on a debt-free basis), in 2012. […]

Downgrades

EVOKE PHARMA (EVOK) Downgraded by Zacks to NEUTRAL

January 15, 2015 0

Zacks Investment Research downgraded shares of EVOKE PHARMA (EVOK) from OUTPERFORM to NEUTRAL on January 15, 2015, with a target price of $8.30. Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. […]

Downgrades

GRANA Y MONTERO (GRAM) Downgraded by Zacks to NEUTRAL

January 15, 2015 0

Zacks Investment Research downgraded shares of GRANA Y MONTERO (GRAM) from OUTPERFORM to NEUTRAL on January 15, 2015, with a target price of $13.50. Grana y Montero SAA operates as a holding company. The company through its subsidiaries operates engineering, construction, oil drilling, data processing services, telecommunications services, distribution of natural gas, and consulting […]

Downgrades

REXAHN PHARMACT (RNN) Downgraded by Zacks to NEUTRAL

January 15, 2015 0

Zacks Investment Research downgraded shares of REXAHN PHARMACT (RNN) from OUTPERFORM to NEUTRAL on January 15, 2015, with a target price of $1.00. REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy […]

Upgrades

BILL BARRETT CP (BBG) Upgraded by Zacks to NEUTRAL

January 15, 2015 0

Zacks Investment Research upgraded shares of BILL BARRETT CP (BBG) from UNDERPERFORM to NEUTRAL on January 15, 2015, with a target price of $10.60. Bill Barrett Corporation, headquartered in Denver, explores for and develops oil and natural gas in the Rocky Mountain region of the United States. The Company has projects in nine basins in the Rocky Mountains […]

Upgrades

Juniper Networks, Inc. (JNPR) Upgraded by Zacks to NEUTRAL

January 15, 2015 0

Zacks Investment Research upgraded shares of Juniper Networks, Inc. (JNPR) from UNDERPERFORM to NEUTRAL on January 15, 2015, with a target price of $23.00. Networking solutions provider, Juniper, posted mixed third-quarter 2014 results wherein the bottom line misses the Zacks Consensus Estimate while the top line matches the same. […]

Upgrades

MULTI-FINELINE (MFLX) Upgraded by Zacks to OUTPERFORM

January 15, 2015 0

Zacks Investment Research upgraded shares of MULTI-FINELINE (MFLX) from NEUTRAL to OUTPERFORM on January 15, 2015, with a target price of $12.50. Multi-Fineline Electronix is a global provider of high-quality, technologically advanced flexible printed circuit and value-added component assembly solutions to the electronics industry. […]